Last 12 months
Inside the activity.
1 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 1,165 | $38.55 | $44,910.75 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 1,446 | $22.30 | $32,245.80 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 21:01 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 914 | $12.21 | $11,159.94 |
DisclosureSEC source: 0001179110-19-011611 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:11 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-011411 · edgar.xml · derivative · entry 5 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 750 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:11 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,275 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-011411 · edgar.xml · derivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,053 Underlying: Common Stock · 1,275 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:11 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 2,025 | $77.37 | $156,674.25 |
DisclosureSEC source: 0001179110-19-011411 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:11 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 750 | $38.55 | $28,912.50 |
DisclosureSEC source: 0001179110-19-011411 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:11 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 1,275 | $35.45 | $45,198.75 |
DisclosureSEC source: 0001179110-19-011411 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 22,127 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · derivative · entry 11 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,773 Underlying: Common Stock · 22,127 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,128 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · derivative · entry 10 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,040 Underlying: Common Stock · 10,128 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,308 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,568 Underlying: Common Stock · 7,308 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,823 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,823 shares Expires 2025-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,734 | $0.00 Strike: $8.71 | $0.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,734 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
SaleCommon Stock | 50,955 | $75.00 | $3,821,625.00 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 6 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 22,127 | $38.55 | $852,995.85 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 10,128 | $22.30 | $225,854.40 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 7,308 | $12.21 | $89,230.68 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 1,823 | $9.60 | $17,500.80 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Vandervoort Adam CChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 2,734 | $8.71 | $23,813.14 |
DisclosureSEC source: 0001179110-19-011358 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Cappucci Gabriel R.Senior VP, Controller and CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,569 | $0.00 Strike: $9.60 | $0.00 |
DisclosureSEC source: 0001179110-19-011357 · edgar.xml · derivative · entry 3 Cappucci Gabriel R. · CIK 0001417243 · Senior VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,734 Underlying: Common Stock · 9,569 shares Expires 2025-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on April 22, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Cappucci Gabriel R.Senior VP, Controller and CAO
|
SaleCommon Stock | 9,569 | $75.00 | $717,675.00 |
DisclosureSEC source: 0001179110-19-011357 · edgar.xml · nonDerivative · entry 2 Cappucci Gabriel R. · CIK 0001417243 · Senior VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,229 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. Read SEC document |
| October 31, 2019 Filed Nov 1, 2019 21:42 UTC |
Cappucci Gabriel R.Senior VP, Controller and CAO
|
Exercise / conversionCommon Stock | 9,569 | $9.60 | $91,862.40 |
DisclosureSEC source: 0001179110-19-011357 · edgar.xml · nonDerivative · entry 1 Cappucci Gabriel R. · CIK 0001417243 · Senior VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:05 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 250 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-011096 · edgar.xml · derivative · entry 5 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,750 Underlying: Common Stock · 250 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:05 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 425 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-011096 · edgar.xml · derivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,328 Underlying: Common Stock · 425 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:05 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 675 | $70.00 | $47,250.00 |
DisclosureSEC source: 0001179110-19-011096 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:05 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 250 | $38.55 | $9,637.50 |
DisclosureSEC source: 0001179110-19-011096 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 20:05 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 425 | $35.45 | $15,066.25 |
DisclosureSEC source: 0001179110-19-011096 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 19:59 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-010774 · edgar.xml · derivative · entry 5 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 500 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 19:59 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 850 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-010774 · edgar.xml · derivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,753 Underlying: Common Stock · 850 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 19:59 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 1,350 | $67.79 | $91,516.50 |
DisclosureSEC source: 0001179110-19-010774 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 19:59 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 500 | $38.55 | $19,275.00 |
DisclosureSEC source: 0001179110-19-010774 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 19:59 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 850 | $35.45 | $30,132.50 |
DisclosureSEC source: 0001179110-19-010774 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 17:46 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 250 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-010354 · edgar.xml · derivative · entry 5 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,500 Underlying: Common Stock · 250 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 17:46 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 425 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-010354 · edgar.xml · derivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,603 Underlying: Common Stock · 425 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 17:46 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 675 | $70.00 | $47,250.00 |
DisclosureSEC source: 0001179110-19-010354 · edgar.xml · nonDerivative · entry 3 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 17:46 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 250 | $38.55 | $9,637.50 |
DisclosureSEC source: 0001179110-19-010354 · edgar.xml · nonDerivative · entry 2 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 17:46 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 425 | $35.45 | $15,066.25 |
DisclosureSEC source: 0001179110-19-010354 · edgar.xml · nonDerivative · entry 1 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,150 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 2,150 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,167 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,004 Underlying: Common Stock · 4,167 shares Expires 2027-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,841 | $0.00 Strike: $12.21 | $0.00 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,681 Underlying: Common Stock · 2,841 shares Expires 2026-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC |
Turitz AndrewSVP - Business Development
|
SaleCommon Stock | 9,158 | $62.27 | $570,268.66 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,986 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019. F2 · price: Represents the weighted average price of transactions ranging from $61.63 to $62.63. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionCommon Stock | 2,150 | $38.55 | $82,882.50 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionCommon Stock | 4,167 | $22.30 | $92,924.10 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 16:26 UTC |
Turitz AndrewSVP - Business Development
|
Exercise / conversionCommon Stock | 2,841 | $12.21 | $34,688.61 |
DisclosureSEC source: 0001179110-19-010238 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:41 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 250 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-010122 · edgar.xml · derivative · entry 10 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,750 Underlying: Common Stock · 250 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:41 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 425 | $0.00 Strike: $35.45 | $0.00 |
DisclosureSEC source: 0001179110-19-010122 · edgar.xml · derivative · entry 9 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,028 Underlying: Common Stock · 425 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:41 UTC |
Levy LewisChief Medical Officer
|
SaleCommon Stock | 675 | $60.00 | $40,500.00 |
DisclosureSEC source: 0001179110-19-010122 · edgar.xml · nonDerivative · entry 6 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:41 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 250 | $38.55 | $9,637.50 |
DisclosureSEC source: 0001179110-19-010122 · edgar.xml · nonDerivative · entry 5 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:41 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionCommon Stock | 425 | $35.45 | $15,066.25 |
DisclosureSEC source: 0001179110-19-010122 · edgar.xml · nonDerivative · entry 4 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:41 UTC |
Levy LewisChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 250 | $0.00 Strike: $38.55 | $0.00 |
DisclosureSEC source: 0001179110-19-010122 · edgar.xml · derivative · entry 8 Levy Lewis · CIK 0001726568 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,000 Underlying: Common Stock · 250 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.